ABSA International
ABSA International

Resources with keywords: vaccines

Training Tools & Resources
EIDC Toolboxes


Considerations for Monkeypox Vaccination
CDC
keywords: Monkeypox, occupational health, poxvirus, vaccines
Monkeypox: Updates on Testing, Vaccination & Treatment
CDC/Infectious Diseases Society of America (IDSA)
23 July 2022

Webinar

keywords: Monkeypox, testing, treatment, vaccines
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
CDC/MMWR
28 June 2022
keywords: children, covid-19, pediatric vaccines, vaccination, vaccines
Rates of COVID-19 Cases and Deaths by Vaccination Status (NEW 6/2, Website, Regulatory)
CDC
keywords: covid-19, transmission, vaccines
COVID-19 Vaccination for Children and Teens with Disabilities (NEW 5/6, Website, Regulatory)
CDC
keywords: children, covid-19, disabilities, vaccines, young adults
Covid-19 vaccines and hearing loss and tinnitus (NEW 5/6, Website, News)
World Health Organization (WHO) - Pharmaceuticals Newsletter
29 April 2022

Rausch, C, et al
(No. 1, 2022) page 18

keywords: covid-19, hearing loss, vaccines
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink (Website, Publication)
JAMA Network
26 April 2022

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022;5(4):e228879. doi:10.1001/jamanetworkopen.2022.8879

Hanson KE, Goddard K, Lewis N, et al.

Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).

keywords: covid-19, side-effects, vaccines
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
15 April 2022

Plumb ID, Feldstein LR, Barkley E, et al.

keywords: covid-19, hospitalization, mRNA, vaccines
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
CDC/MMWR
25 February 2022

Malenfant JH, Joyce A, Choi MJ, et al.
The ACIP has expanded the recommendation for Ebola vaccine to health care personnel at special pathogens treatment centers and laboratorians and support staff members at Laboratory Response Network facilities.

keywords: ebola, vaccines
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 (Website, Publication)
CDC/MMWR
18 December 2021

Klein NP, Stockwell MS, Demarco M, et al.
Two doses protect against COVID-19–associated emergency department and urgent care encounters among children and adolescents. However, vaccine effectiveness (VE) was lower during Omicron predominance and decreased with time since vaccination; a booster dose restored VE to 81% among adolescents aged 16–17 years. Overall, 2-dose VE against COVID-19–associated hospitalization was 73%–94%.

keywords: covid-19, omicron, vaccines

Not a member and would like updates and notifications?

ABSA International
1200 Allanson Road, Mundelein, IL 60060-3808
1-866-425-1385 (toll free) or 847-949-1517
info@absa.org | Contact ABSA

ABOUT | MEMBERSHIP | NEWS/COMMUNITY | RESOURCES | PUBLICATIONS | CREDENTIALS | PROFESSIONAL DEVELOPMENT

For a complete view of the web presence of ABSA International, see the ABSA Portal page.

Copyright © ABSA International. All Rights Reserved.  Privacy Policy

ABSA International does not endorse, promote, review, or warrant the accuracy of the products and services offered by those parties who link to the ABSA International website. The links are merely provided as a convenience to the visitors of this site, and ABSA International may or may not be compensated for permitting the link to be displayed on this page.

Go to Top